|
Volumn 165, Issue 5, 2008, Pages 621-630
|
A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZODIAZEPINE;
CENTRAL STIMULANT AGENT;
CITALOPRAM;
CLOMIPRAMINE;
ESCITALOPRAM;
FLUOXETINE;
FLUVOXAMINE;
MOOD STABILIZER;
NEUROLEPTIC AGENT;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
COGNITIVE THERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
OBSESSIVE COMPULSIVE DISORDER;
OUTPATIENT DEPARTMENT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCORING SYSTEM;
STRESS MANAGEMENT;
YALE-BROWN OBSESSIVE COMPULSIVE SCALE;
ADOLESCENT;
ADULT;
AGED;
CHROMATOGRAPHY, GAS;
CLOMIPRAMINE;
COGNITIVE THERAPY;
COMBINED MODALITY THERAPY;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
OBSESSIVE-COMPULSIVE DISORDER;
SEROTONIN UPTAKE INHIBITORS;
|
EID: 41549086859
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.2007.07091440 Document Type: Article |
Times cited : (223)
|
References (52)
|